Clinical Trials Directory

Trials / Completed

CompletedNCT07424989

Antibiotic Therapies for Urinary Tract Infections and Their Impact on the Gut Microbiota

Status
Completed
Phase
Study type
Observational
Enrollment
61 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A urinary tract infection requires antibiotic treatment. While this treatment is intended to eliminate bacteria from the urine, it may also facilitate the development of resistant strains in the digestive tract. Patients are asked to provide stool samples on several occasions so that any potential side effects of this treatment on the digestive flora can be analysed.

Detailed description

Each of us has billions of bacteria in our intestines that aid digestion (scientifically known as the gut microbiota), some of which can "mutate", i.e. adapt to resist antibiotics. Although this is usually harmless, these bacteria can sometimes cause infections. Hence the importance of better understanding this phenomenon, known as the 'collateral effect on flora of otherwise beneficial antibiotic treatment'. The investigators already know that not all antibiotics are equivalent, with some having a stronger 'collateral effect'. However, the risk classification remains poorly understood. Recent advances in laboratory stool analysis now make it possible to better analyse this phenomenon. The ultimate goal is to identify treatment regimens that are both highly effective in treating urinary tract infections and have the least possible ecological impact.

Conditions

Timeline

Start date
2021-07-04
Primary completion
2025-05-28
Completion
2025-05-28
First posted
2026-02-20
Last updated
2026-02-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07424989. Inclusion in this directory is not an endorsement.

Antibiotic Therapies for Urinary Tract Infections and Their Impact on the Gut Microbiota (NCT07424989) · Clinical Trials Directory